Carregant...
2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control
Current anti-seizure drugs (ASDs) are believed to reduce neuronal excitability through modulation of ion channels and transporters that regulate excitability at the synaptic level. While most patients with epilepsy respond to ASDs, many remain refractory to medical treatment but respond favorably to...
Guardat en:
| Publicat a: | Front Cell Neurosci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503754/ https://ncbi.nlm.nih.gov/pubmed/31114484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2019.00172 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|